Clinical efficacy of Kasakartari Gutika in the management Kasa in Tamaka Shwasa w.s.r. to Bronchial Asthma

2019 ◽  
Vol 4 (03) ◽  
Author(s):  
Pallavi T. Pawar ◽  
P. D. Londhe ◽  
C. S. Majgaonkar
Keyword(s):  
Bronchial Asthma ◽  
Clinical Efficacy ◽  
Prominent Symptom ◽  
Effective Remedy ◽  
Trial Drug

Background: The disease Kasa and Tamaka Shwasa mentioned by Acharya Charaka separately, both the disease are originating from Pranavaha Srotas and can damage Pranavaha Srotas permanently. Especially in Tamaka Shwasa Vyadhi, Kasa is very common as a prominent symptom. In fact patient gets more detoriated after onset of Kasa Vega and fills better when it gets subside. Though Tamaka Shwasa Vyadhi is Pitta Samudbhava, Kapha and Vata are always predominant factors. The Strotorodha made by Styana Kapha provocate Vayu excessively and result into Kasa Vega as symptom. According to Ayurveda the contain of Kasakartari Gutika is act as Kasa-shwashar property and hence for present study Kasakartari Gutika was selected as trial drug for treating the patient of Kasa in Tamaka Shwasa. Aim: To study the efficacy of ‘Kasakartari Gutika’ in the management of Kasa in Tamaka Shwasa w.s.r. to Bronchial Asthma. Material and Methods: Total 30 paients of Kasa in Tamaka Shwasa from OPD and IPD unit of Dr. M. N. Agashe Hospital, Satara, were selected and treated with Kasakartari Gutika 1gm B.D. for the duration of 2 month. Result: Maximum 81.81% relief was observed in Kshudhamandya and 80.64% relief was observed in Ayasenshwasa and 77.5% relief was observed in Kasa. Conclusion: The compound formulation ‘Kasakartari Gutika’ was found as an effective remedy for Kasa in Tamaka Shwasa. The parameters like Kasa, Ayasenshwasa and Kshudhamandya shows that they are highly significant result

Clinical Study of Shirishadi tablet in the management of Tamaka Shvasa w.s.r. to Bronchial Asthma

2017 ◽  
Vol 2 (4) ◽  
Author(s):  
Pankaj Chhayani ◽  
Hemang Raghavani ◽  
Dhananjay Patel
Keyword(s):  
Internal Medicine ◽  
Clinical Study ◽  
Side Effects ◽  
Bronchial Asthma ◽  
Medical Science ◽  
Signs And Symptoms ◽  
Effective Remedy ◽  
All Diseases

Tamaka Shvasa is described as a most difficult to cure (Yapya) among all diseases in Ayurveda. In present study Tamaka Shvasa is correlated with Bronchial Asthma because of its symptomatology is much similar with Tamaka Shvasa. In modern medical science, steroids and bronchodilators are mainly used for its management, but they cause certain side effects. Present study was undertaken to provide safe and effective remedy for Tamaka Shvasa through Ayurvedic medicaments. Shirishadi tablet was given as internal medicine for 30 days. Upto 60% relief was found in signs and symptoms of Tamaka Shvasa.

Study of the efficacy of Pathadi Ghanavati with Lajamanda in the management of Aamatisara

2019 ◽  
Vol 4 (03) ◽  
Author(s):  
Madhura Jadhav ◽  
P. D. Londhe
Keyword(s):  
Acute Diarrhoea ◽  
Public Health Problem ◽  
World Health ◽  
Important Public Health Problem ◽  
Loose Motion ◽  
Economic Class ◽  
Watery Stool ◽  
Health Organization ◽  
Effective Remedy ◽  
Trial Drug

Acute Diarrhoea is an important public health problem worldwide. The World Health Organization estimates that there are more than 1000 million cases of Acute Diarrhoea. Loose motion less than 2 weeks that labelled as Acute Diarrhoea. Diarrhoea is described in Ayurvedic classics with the name of ‘Atisara’. It means passing of excessive flow of watery stool through anus. Most important factor in the pathogenesis of Aamatisara is Mandagni. In present study 50 patients of Aamatisara were selected from OPD and IPD of Kayachikitsa department. For the clinical study Pathadi Ghanavati and Lajamanda was selected as the trial drug which was given for the duration of 7 days in the dose of 1gm twice a day. It was observed that 32% patients were from the age group 51-60 years, 70% were females, 62% were from lower-middle socio economic class. Sama Jivha was found in all the patients. Among results loose motion showed 98.75% relief, 97.82% showed improvement in Udarashoola, 97.43% improvement in Agnimandya and Daurbalya each, 100% relief was seen in Aruchi. All the symptoms showed highly significant results. Hence it can be concluded that Pathadi Ghanavati and Lajamanda is very effective remedy in the patients of Aamatisara.

Clinical Efficacy of Dhatryadi Ghanavati in Shvitra (Vitiligo)

2017 ◽  
Vol 1 (4) ◽  
Author(s):  
Manjiri Walinjkar ◽  
P.D. Londhe ◽  
S. R. Makhare ◽  
Anil Avhad
Keyword(s):  
Clinical Efficacy ◽  
Skin Disorder ◽  
Total Population ◽  
Social Stigma ◽  
Term Treatment ◽  
Effective Therapy ◽  
Long Term Treatment ◽  
Percentage Area ◽  
Effective Remedy

Background: Shvitra (vitiligo) is a kind of skin disorder comprising of white coloured skin patches which is considered as a social stigma. Worldwide prevalence of Vitiligo is observed as 1% of the total population. Due to the chronic nature, long term treatment, lack of uniform effective therapy and unpredictable course the disease is usually very demoralizing for patients. Aim: To study the efficacy of ‘Dhatryadi Ghanavati’ in the management of Shvitra. Materials and Methods: Total 50 patients of Shvitra from OPD and IPD unit of Dr. M.N. Agashe Hospital, Satara were selected and provided with Dhatryadi Ghanavati 1gm B.D. for the duration of 3 months. Results: 100% relief was observed in Daha and Kandu followed by 83.33% relief was observed in Rukshata. 34.51% improvement was seen in number of patches, 34.82% in size of patches and 34.29% in percentage area involved. Color of the patches was improved by 69.01% whereas 44% improvement was seen in hair discoloration. Conclusion: The compound formulation ‘Dhatryadi Ghanavati’ was found as an effective remedy for ‘Shvitra’. The parameters like number of patches, size of patches, percentage area involved and colour of patches showed statistically highly significant results.

Clinical Efficacy of Ayurvedic formulations, Kanakasava and Trivrit Churna, in the Management of Bronchial Asthma: A Prospective, Open-label, Multicentric Study

2020 ◽  
Vol 4 (1) ◽  
pp. 1-9
Author(s):  
Narayanam Srikanth ◽  
Shruti Khanduri ◽  
Sobaran Singh ◽  
Thugutla Maheswar ◽  
Rakesh Rana ◽  
...  
Keyword(s):  
Bronchial Asthma ◽  
Clinical Efficacy ◽  
Open Label ◽  
Multicentric Study

Clinical Efficacy of Treatment of Children with Bronchial Asthma, Population in Remote Areas in Terms of Regional Respiratory Centre as Sanatorium Type: Work Results for 10 Years

10.12737/7279 ◽  
2014 ◽  
Vol 21 (4) ◽  
pp. 102-108
Author(s):  
Ермакова ◽  
I. Ermakova
Keyword(s):  
Bronchial Asthma ◽  
Clinical Efficacy ◽  
Clinical Examination ◽  
Main Group ◽  
Remote Areas ◽  
Number Of Children ◽  
Children With Asthma ◽  
Respiratory Centre ◽  
Severe Degree ◽  
Efficacy Of Treatment

The purpose of this work is to improve the specialized medical care for children with bronchial asthma, people living in remote areas and villages. Materials and methods: The study involved 1,024 children with asthma (solid sample, 2003) which were observed in period of 2003 to 2013. There are 391 children-villagers as the main group; clinical examination was carried out by district pediatrician and 633 children as regional city residents (the comparison group); clinical examination was carried out by district pediatrician together with pulmonologist or allergist. The author used the methods of observation (solid documentary and selective, current, prospective) and the method of expert evaluations. Results: a significant discrepancy (p=0,03) in the evaluation by district pediatrician, practitioner or family doctor) of severity bronchial asthma and absence of bronchial asthma treatment in 28% of patients of the main group has been demonstrated in 2003. The discrepancy in the diagnosis of bronchial asthma of light degree and medium severe degree (p=0.03) were detected by a positively accepted method (examination of pulmonologist/allergist, clinical and instrumental examination, 2008). Clinical efficacy of treatment of children with bronchial asthma as residents in regional respiratory centre has been proven. For ten years the number of children with BA decreased by 25%, the number of bronchial asthma patients with moderate current (p=0.03) decreased and the number of patients with medium severe degree bronchial asthma (p=0.01) significantly increased. In 2013, the patients of the main group observations received adequate basic therapy bronchial asthma; number of children with asthma decreased in 2 times (p=0.03); the calls in the ambulance and the need for hospitalization decreased more than 2 times (p=0.03); the number of children with controlled bronchial asthma increased from 26 to 64% (p=0.05).

scholarly journals The clinical efficacy of prophylactic therapy of the bronchial asthma in children with an early and late onset of the disease

2013 ◽  
Vol 17 (1 (65)) ◽  
pp. 106-109
Author(s):  
S. I. Sazhyn
Keyword(s):  
Bronchial Asthma ◽  
Clinical Efficacy ◽  
Early Onset ◽  
Odds Ratio ◽  
Late Onset ◽  
School Age Children ◽  
Prophylactic Therapy ◽  
School Age ◽  
Asthma In Children ◽  
Basic Treatment

The results of the clinical efficacy of basic treatment of school-age children with bronchial asthma have been presented. It has been found that patients with an early-onset phenotype of asthma had a higher risk of not gaining control over the symptoms of the disease (odds ratio – 6,0) and exacerbations (odds ratio – 2,7) compared with children whose disease set in after six years.

Clinical efficacy of Kapha Ketu Rasa on Tamaka Swasa

2016 ◽  
Vol 1 (3) ◽  
Author(s):  
Anuroopa HK ◽  
Shankar Gouda ◽  
Madhava Diggavi
Keyword(s):  
Clinical Study ◽  
Success Rate ◽  
Bronchial Asthma ◽  
Clinical Efficacy ◽  
Eosinophil Count ◽  
Clinical Effect ◽  
Clinical Success ◽  
Clinical Success Rate ◽  
Therapeutic Effects

Context: Compound drugs are scientifically formulated aiming to get the desired therapeutic effects through synergy. Kapha Ketu Rasa is one such compound drug which is a classical herbo mineral marine Khalvi Rasayana judicially containing Shankha Bhasma, Vatsanabha, Tankana and Pippali. Treating GERD along with the treatment of bronchial asthma will enhance the clinical success rate. At this juncture, it is worth to notice the pharmacology of Kapha Ketu Rasa in the same perspective. Aims: To study the clinical effect of Kapha Ketu Rasa on Tamaka Swasa (Bronchial asthma). Materials and Methods: 30 Patients of Tamaka Swasa irrespective of age, sex, religion etc., were randomly selected and treated with 125 mg of Kapha Ketu Rasa capsules twice a day with Ardraka Swarasa before meals for 21 days, then followed for 21 more days. Results: The clinical study showed statistically highly significant improvement in both subjective and objective parameters viz. Kasa (91%), Ghurghurata (83%) and Swasakruchrata (82%) including decrease in AEC, ESR, Differential eosinophil count and PEF was also statistically significantly improved. Conclusions: Kapha Ketu Rasa is an effective Vyadhi Pratyanika herbo mineral Shamana Rasayana in the management of Tamaka Swasa.

The effectiveness use of the combined inhalation glucocorticosteroids in the therapy of bronchial asthma

10.12737/5482 ◽  
2014 ◽  
Vol 8 (1) ◽  
pp. 1-4
Author(s):  
Лепухова ◽  
O. Lepukhova
Keyword(s):  
Positive Result ◽  
Bronchial Asthma ◽  
Clinical Efficacy ◽  
Active Ingredient ◽  
Inflammatory Activity ◽  
Mixed Form ◽  
Inhalation Device ◽  
Acute Infections ◽  
Aerosol Inhalation ◽  
Pregnancy And Lactation

The effectiveness and comfort of using combined inhalation glucococrticosteroids in the patients with uncontrolled bronchial asthma of medium degree and mixed form was studied. As the reaction of application of different combined inhalation glucococrticosteroids for treating bronchial asthma of the same degree can be different, it is necessary to select not only the substance but also the form of using the preparations. So, for choosing the most effective preparation it was carried out an experiment with 40 patients aged from 18 to 65 with uncontrolled bronchial asthma of medium degree. The authors have excluded patients with: hyper sensibility to preparation components, acute infections of airways, pregnancy and lactation, presence a serious accompanying illness form. In the process of observation 2 patients dropped out of the experiment for different reasons. As a result 38 patients took part in research. The patients were divided into 2 groups. These patients received combined inhalation glucocorticosteroids in equivalent doses taking into account anti-inflammatory activity of glucocorticosteroid active ingredient and features of the inhalation device. The first group of patients used Foster aerosol inhalation in the dose of 100 mcg+ 6 mcg/1 dose: container 120 doses. The second group of patients received Foradil Kombi on form of gelatinous capsules, size 3 mg+12 mcg/ 1 dose together with powder for inhalations and included with the device for inhalation. Clinical efficacy of the treatment was assessed after 4 months of treatment and the positive result was detected in the second group.

Sign in / Sign up

Export Citation Format

Share Document